News

9 March, 2012

New facilities at Medicon Village

SPAGO has moved to larger and well equipped facilities at Medicon Village. The new address can be found under “Contact”.

20 February, 2012

Production of GLP-tox material

SPAGO Imaging has signed a contract with Syntagon AB to produce material for the preclinical toxicity studies required for regulatory documentation of product safety.

31 January, 2012

SPAGO on nanomedicine tour in US

SPAGO joined the Nanomedicine Partnering Mission to Boston and Research Triangle in North Carolina, USA organized by Medicon Valley Alliance and Nano Connect Scandinavia. A Swedish-Danish delegation of researchers, business developers and representatives of authorities met with their counterparts in academia, biotechs and organizations promoting nanomedicine and life science during a week to share information and build relationships for future interactions and collaborations. Harvard, MIT, Boston University, Merrimack Pharmaceuticals, Duke University, University Chapel Hill and Liquidia Technologies were among the places visited. Read Rapidus blogg (in Swedish) here.

17 January, 2012

Moving to Medicon Village

SPAGO will move with the Incubator to Medicon Village (previous AstraZeneca facilities in Lund). Larger lab and improved infrastructure including access to a wide range of analytical equipment will be beneficial to our work. For media coverage (in Swedish) – please use the following links: Text and Picture

8 December, 2011

Incubator company receives 3.6 MSEK

SPAGO Imaging to receive 3.6 MSEK in financing from VINNOVA’s “Forska & Väx” program.

Read the article from The City of Lund here (in Swedish).